chr19-38565181-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 3P and 12B. PM5PP2BP4_StrongBP6_Very_Strong
The NM_000540.3(RYR1):c.12847G>A(p.Glu4283Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000025 in 1,160,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E4283V) has been classified as Pathogenic.
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR1 | NM_000540.3 | c.12847G>A | p.Glu4283Lys | missense_variant | 91/106 | ENST00000359596.8 | NP_000531.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR1 | ENST00000359596.8 | c.12847G>A | p.Glu4283Lys | missense_variant | 91/106 | 5 | NM_000540.3 | ENSP00000352608 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000608 AC: 9AN: 147930Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00273 AC: 18AN: 6588Hom.: 0 AF XY: 0.00204 AC XY: 9AN XY: 4414
GnomAD4 exome AF: 0.0000198 AC: 20AN: 1012596Hom.: 0 Cov.: 30 AF XY: 0.0000187 AC XY: 9AN XY: 480386
GnomAD4 genome AF: 0.0000608 AC: 9AN: 147930Hom.: 0 Cov.: 32 AF XY: 0.0000555 AC XY: 4AN XY: 72074
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 12, 2018 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
RYR1-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at